Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Hit-and-run Edit  
1 comment  




2 References  





3 Abbott interview about polymorphs  





4 Sold{where}  
1 comment  













Talk:Ritonavir




Page contents not supported in other languages.  









Article
Talk
 

















Read
Edit
Add topic
View history
 








Tools
   


Actions  



Read
Edit
Add topic
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Get shortened URL
Download QR code
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 



Hit-and-run Edit[edit]

The quality of the text removed was not highly encyclopedic. "Delete now and ask questions never" could be attributed to style.

Change in question.

Text removed:

Research that led to the drug's development was financed by a $3,500,000 federal grant through the National Institutes of Health (NIH) and over $200,000,000 by Abbott Labs. Most of the $200,000,000 figure cited by Abbott paid for clinical trials—despite NIH offering to pay for them—because Abbott was concerned about "public interest" responses to the high prices they projected Norvir would command.[1]

But to do the edit (deletion):

Seems very suspicious to me that there are ulterior motives[2][3] , what do other people think? Thanks 96.26.79.253 (talk) 12:14, 5 July 2014 (UTC)[reply]

References[edit]

  1. ^ James Love (2004-06-03). "How much has the public invested in ritonavir, and how much has Abbott?". Essential Inventions. Retrieved 2008-05-06..
  • ^ Newman, Lily Hay (17 June 2014). "Wikipedia Is Smoking Out Paid Editors". Slate/Future Tense. The Slate Group, a Graham Holdings Company. Retrieved 5 July 2014.
  • ^ Ford, Sam (10 June 2014). "Narrowing the Chasm Between PR Professionals and Wikipedia". Harvard Business Review Blog Network. Harvard Business School Publishing. Retrieved 5 July 2012.
  • Abbott interview about polymorphs[edit]

    There is a striking set of four interviews/presentations, whose transcripts are available here:

    Parts of it were quoted in https://onlinelibrary.wiley.com/doi/full/10.1002/anie.201410356 including:

    A company’s size and the collective IQs of their scientists have no relationship to this problem.

    But that paper didn't have a current source for the transcript, so I wanted to mention it here in case others are looking for it. JesseW, the juggling janitor 01:54, 16 May 2020 (UTC)

    Sold{where}[edit]

    Ritonavir (RTV), sold[where?] under the brand name Norvir, is an antiretroviral medication used along with other medications to treat HIV/AIDS.

    I added the flag. The reader shouldn't have to finish the lead to puzzle out that it quite likely implies "sold globally", which I certainly can't add myself to resolve the flag, because I know nothing about this topic whatsoever. — MaxEnt 17:02, 5 November 2021 (UTC)[reply]


    Retrieved from "https://en.wikipedia.org/w/index.php?title=Talk:Ritonavir&oldid=1195419110"

    Categories: 
    Start-Class pharmacology articles
    High-importance pharmacology articles
    WikiProject Pharmacology articles
    Start-Class AIDS articles
    High-importance AIDS articles
    WikiProject AIDS articles
    Start-Class medicine articles
    Mid-importance medicine articles
    Start-Class WikiProject Medicine Translation Task Force articles
    High-importance WikiProject Medicine Translation Task Force articles
    WikiProject Medicine Translation Task Force articles
    All WikiProject Medicine pages
     



    This page was last edited on 13 January 2024, at 19:40 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki